PRU
62
6
MCHP
55
-7
TEL
66
-2
GS
66
-3
ETR
75
-2
UA
56
8
CHRW
71
-2
AVY
46
2
WMB
60
-2
QCOM
63
3
PFG
53
-2
DNB
48
-2
MTCH
60
10
FTI
71
-2
CCI
34
13
FLS
67
-2
ED
52
2
DD
38
-2
IR
71
-4
NWL
48
5
PRU
62
6
MCHP
55
-7
TEL
66
-2
GS
66
-3
ETR
75
-2
UA
56
8
CHRW
71
-2
AVY
46
2
WMB
60
-2
QCOM
63
3
PFG
53
-2
DNB
48
-2
MTCH
60
10
FTI
71
-2
CCI
34
13
FLS
67
-2
ED
52
2
DD
38
-2
IR
71
-4
NWL
48
5
Financhill
Back

OptimizeRx 10K Form

Buy
53

OPRX
OptimizeRx

Last Price:
$11.91
Seasonality Move:
4.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-05 10Q OPRX/OptimizeRx Quarterly
2020-05-06 10Q OPRX/OptimizeRx Quarterly
2020-03-26 10K OPRX/OptimizeRx Annual
2019-11-05 10Q OPRX/OptimizeRx Quarterly
2019-08-07 10Q OPRX/OptimizeRx Quarterly
2019-05-08 10Q OPRX/OptimizeRx Quarterly

Receive OPRX News And Ratings

See the #1 stock for the next 7 days that we like better than OPRX

OPRX Financial Statistics

Sales & Book Value

Annual Sales: $92.1M
Cash Flow: $3.8M
Price / Cash Flow: 35.83
Annual Sales: $6.29
Price / Book: 1.94

Profitability

EPS (TTM): -0.84000
Net Income (TTM): $-15.4M
Gross Margin: $59.4M
Return on Equity: -13.03%
Return on Assets: -9.03%

OptimizeRx Earnings Forecast

Key OptimizeRx Financial Ratios

  • The Gross Profit Margin over the past 18 years for OPRX is 64.45%.
  • The Selling, General & Administrative Expenses for OPRX have been equal to 66.50% of Gross Profit Margin.
  • The Research & Development expenses have been 2.49% of Revenue.
  • The Net Earning history of OPRX is -21.83% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 7 years.

OptimizeRx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: OPRX
CUSIP: 68401U
Website: optimizerx.com

Debt

Debt-to-Equity Ratio: 0.28
Current Ratio: 2.82
Quick Ratio: 2.69

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 18.48

OPRX Technical Analysis vs Fundamental Analysis

Buy
53
OptimizeRx (OPRX) is a Buy

Is OptimizeRx a Buy or a Sell?

  • OptimizeRx stock is rated a Buy
    The current OptimizeRx [OPRX] share price is $12.20. The Score for OPRX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.